Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, CSR

MedShr Receives World Summit Award and Explores Growth Opportunities in the Mayor's International Business Programme in Vienna


LONDON, March 20, 2018 /PRNewswire/ --

MedShr - the app for doctors - will receive a World Summit Award in recognition of its global impact for social good in Vienna this week. Founder and CEO of MedShr, Dr Asif Qasim says: "We are thrilled to be recognised by the WSA for our achievements in supporting doctors to improve healthcare for patients around the world."

     (Logo: http://mma.prnewswire.com/media/535939/MedShr_Logo.jpg )

The WSA Global Congress will award MedShr a trophy for the best health and wellbeing product at Vienna City Hall on 22nd March, in front of UN representatives and ICT ministries. Dr Qasim will present MedShr to an international Grand Jury for a chance to win the overall health and wellbeing category. The WSA recognises the part that digital innovation plays in creating sustainable social change and impact worldwide.

MedShr will also join the London Mayor's International Business Programme's B2B Life Science and FinTech Mission which is also in Vienna this week. The programme helps ambitious high-growth companies from London's technology, life sciences and urban sectors to expand their businesses internationally.

MedShr works with a range of educational partners such as Health Education England and BMJ Case Reports, as well as a number of medical device and pharmaceutical companies. MedShr offers an unrivalled digital channel for these companies to support physicians through sponsored medical education.

The London startup, which was founded in 2015, provides a private, professional platform for doctors to discuss clinical cases, share knowledge, and improve patient care. The app and web platform now has over 500,000 members in 180 countries, with cases in all specialties.

About MedShr 

MedShr is an app and platform for the medical community to share and discuss clinical cases. To date, there are half a million members on MedShr engaged in active learning through case discussion.

About the WSA 

The World Summit Award is a global initiative within the framework of the United Nations World Summit on the Information Society (WSIS). WSA is the only ICT event worldwide, that reaches the mobile community in over 180 countries.

About The Mayor's International Business Programme 

The Mayor's International Business Programme invites Life Science and Health Tech businesses to join them for a One Day Trade Mission to Vienna. This Mission aims to assist high-growth companies seeking to identify partnerships and to explore business opportunities.

Press contact:
Stefania Gancitano, Marketing Executive
+44(0)7795421245


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...

at 08:00
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American...



News published on and distributed by: